BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 33175633)

  • 1. Platelets Promote Ang II (Angiotensin II)-Induced Atrial Fibrillation by Releasing TGF-β1 (Transforming Growth Factor-β1) and Interacting With Fibroblasts.
    Liu Y; Lv H; Tan R; An X; Niu XH; Liu YJ; Yang X; Yin X; Xia YL
    Hypertension; 2020 Dec; 76(6):1856-1867. PubMed ID: 33175633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MFGE8 attenuates Ang-II-induced atrial fibrosis and vulnerability to atrial fibrillation through inhibition of TGF-β1/Smad2/3 pathway.
    Ge Z; Chen Y; Wang B; Zhang X; Yan Y; Zhou L; Zhang Y; Xie Y
    J Mol Cell Cardiol; 2020 Feb; 139():164-175. PubMed ID: 31958465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of Transient Receptor Potential Canonical Type 3 Channel via AT1R/TGF-
    He R; Zhang J; Luo D; Yu Y; Chen T; Yang Y; Yu F; Li M
    Oxid Med Cell Longev; 2019; 2019():4025496. PubMed ID: 31871548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NPR-C (Natriuretic Peptide Receptor-C) Modulates the Progression of Angiotensin II-Mediated Atrial Fibrillation and Atrial Remodeling in Mice.
    Jansen HJ; Mackasey M; Moghtadaei M; Liu Y; Kaur J; Egom EE; Tuomi JM; Rafferty SA; Kirkby AW; Rose RA
    Circ Arrhythm Electrophysiol; 2019 Jan; 12(1):e006863. PubMed ID: 30636477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atrial fibrillation induces myocardial fibrosis through angiotensin II type 1 receptor-specific Arkadia-mediated downregulation of Smad7.
    He X; Gao X; Peng L; Wang S; Zhu Y; Ma H; Lin J; Duan DD
    Circ Res; 2011 Jan; 108(2):164-75. PubMed ID: 21127293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA PVT1 regulates atrial fibrosis via miR-128-3p-SP1-TGF-β1-Smad axis in atrial fibrillation.
    Cao F; Li Z; Ding WM; Yan L; Zhao QY
    Mol Med; 2019 Mar; 25(1):7. PubMed ID: 30894138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor-β-mediated CD44/STAT3 signaling contributes to the development of atrial fibrosis and fibrillation.
    Chang SH; Yeh YH; Lee JL; Hsu YJ; Kuo CT; Chen WJ
    Basic Res Cardiol; 2017 Sep; 112(5):58. PubMed ID: 28871329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of natriuretic peptide clearance receptor attenuates TGF-β1-induced selective atrial fibrosis and atrial fibrillation.
    Rahmutula D; Zhang H; Wilson EE; Olgin JE
    Cardiovasc Res; 2019 Feb; 115(2):357-372. PubMed ID: 30239604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The crucial role of activin A/ALK4 pathway in the pathogenesis of Ang-II-induced atrial fibrosis and vulnerability to atrial fibrillation.
    Wang Q; Yu Y; Zhang P; Chen Y; Li C; Chen J; Wang Y; Li Y
    Basic Res Cardiol; 2017 Jul; 112(4):47. PubMed ID: 28639003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoproteasome Subunit β5i Promotes Ang II (Angiotensin II)-Induced Atrial Fibrillation by Targeting ATRAP (Ang II Type I Receptor-Associated Protein) Degradation in Mice.
    Li J; Wang S; Zhang YL; Bai J; Lin QY; Liu RS; Yu XH; Li HH
    Hypertension; 2019 Jan; 73(1):92-101. PubMed ID: 30571551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LOXL2 Inhibitor Attenuates Angiotensin II-Induced Atrial Fibrosis and Vulnerability to Atrial Fibrillation through Inhibition of Transforming Growth Factor Beta-1 Smad2/3 Pathway.
    Wu Y; Can J; Hao S; Qiang X; Ning Z
    Cerebrovasc Dis; 2022; 51(2):188-198. PubMed ID: 34515064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of TGF-β1/α-SMA/Col I Profibrotic Pathway in Fibroblasts by Galectin-3 Contributes to Atrial Fibrosis in Experimental Models and Patients.
    Shen H; Wang J; Min J; Xi W; Gao Y; Yin L; Yu Y; Liu K; Xiao J; Zhang YF; Wang ZN
    Cell Physiol Biochem; 2018; 47(2):851-863. PubMed ID: 29807358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of platelet activation by clopidogrel prevents hypertension-induced cardiac inflammation and fibrosis.
    Jia LX; Qi GM; Liu O; Li TT; Yang M; Cui W; Zhang WM; Qi YF; Du J
    Cardiovasc Drugs Ther; 2013 Dec; 27(6):521-30. PubMed ID: 23887740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of the Rho/ROCK Pathway in Ang II and TGF-β1-Induced Atrial Remodeling.
    Liu LJ; Yao FJ; Lu GH; Xu CG; Xu Z; Tang K; Cheng YJ; Gao XR; Wu SH
    PLoS One; 2016; 11(9):e0161625. PubMed ID: 27611832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PU.1 inhibition attenuates atrial fibrosis and atrial fibrillation vulnerability induced by angiotensin-II by reducing TGF-β1/Smads pathway activation.
    Hu J; Zhang JJ; Li L; Wang SL; Yang HT; Fan XW; Zhang LM; Hu GL; Fu HX; Song WF; Yan LJ; Liu JJ; Wu JT; Kong B
    J Cell Mol Med; 2021 Jul; 25(14):6746-6759. PubMed ID: 34132026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fus knockdown inhibits the profibrogenic effect of cardiac fibroblasts induced by angiotensin II through targeting Pax3 thereby regulating TGF-β1/Smad pathway.
    Wang G; Wu H; Liang P; He X; Liu D
    Bioengineered; 2021 Dec; 12(1):1415-1425. PubMed ID: 33896391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adipose Triglyceride Lipase Deficiency Aggravates Angiotensin II-Induced Atrial Fibrillation by Reducing Peroxisome Proliferator-Activated Receptor α Activation in Mice.
    Han X; Zhang YL; Zhao YX; Guo SB; Yin WP; Li HH
    Lab Invest; 2023 Jan; 103(1):100004. PubMed ID: 36748188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SHP-1 alleviates atrial fibrosis in atrial fibrillation by modulating STAT3 activation.
    Zang X; Zhao Z; Chen K; Song W; Ma J; Fu H; Wang X; Zhao Y
    Exp Biol Med (Maywood); 2023 Jun; 248(11):979-990. PubMed ID: 37226737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the MAPKs/TGF-β1/TRAF6 signaling pathway in postoperative atrial fibrillation.
    Zhang D; Chen X; Wang Q; Wu S; Zheng Y; Liu X
    PLoS One; 2017; 12(3):e0173759. PubMed ID: 28323847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Klotho inhibits angiotensin II-induced cardiac hypertrophy, fibrosis, and dysfunction in mice through suppression of transforming growth factor-β1 signaling pathway.
    Ding J; Tang Q; Luo B; Zhang L; Lin L; Han L; Hao M; Li M; Yu L; Li M
    Eur J Pharmacol; 2019 Sep; 859():172549. PubMed ID: 31325434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.